Literature DB >> 20875389

Gas chromatography-mass spectrometry-based simultaneous quantitative analytical method for urinary oxysterols and bile acids in rats.

Bhowmik Salil Kumar1, Bong Chul Chung, Young-Joo Lee, Hong Jae Yi, Byung-Hoon Lee, Byung Hwa Jung.   

Abstract

A simultaneous quantitative assay method for urinary oxysterols and bile acids using GC-MS was developed to investigate the mechanism of liver toxicity induced by drugs or chemicals. Sample preparations were optimized by exploring various extraction solvents, derivatization reagents, and hydrolysis methods to achieve reliable and maximum sensitivity for these two different compound classes. As a result, satisfactory accuracy, precision, and sensitivity were obtained in the validation. The method was then applied to quantify urinary oxysterols and bile acids produced from liver toxicity induced by atorvastatin (250 mg/kg/day). From the results, increases in bile acid levels and decreases in the concentration ratio between cholic acid and chenodeoxycholic acid, which are the distinguishing phenomena observed in serum or bile for liver toxicity, were also observed in urine. Additionally, the mechanism of liver toxicity was investigated with the urinary concentration ratio of product to precursor in the metabolic pathway from cholesterol to bile acids. The results indicated that enzyme activities related to the production and degradation of bile acids, not oxysterols, were significantly changed from liver toxicity. Thus, it was concluded that urinary levels of oxysterols and bile acids could be useful tools for checking liver toxicity and investigating its mechanism.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20875389     DOI: 10.1016/j.ab.2010.09.031

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  12 in total

1.  Long-term high-dose atorvastatin decreases brain oxidative and nitrosative stress in a preclinical model of Alzheimer disease: a novel mechanism of action.

Authors:  Eugenio Barone; Giovanna Cenini; Fabio Di Domenico; Sarah Martin; Rukhsana Sultana; Cesare Mancuso; Michael Paul Murphy; Elizabeth Head; D Allan Butterfield
Journal:  Pharmacol Res       Date:  2010-12-27       Impact factor: 7.658

Review 2.  A review of analytical platforms for accurate bile acid measurement.

Authors:  Mainak Dutta; Jingwei Cai; Wei Gui; Andrew D Patterson
Journal:  Anal Bioanal Chem       Date:  2019-05-24       Impact factor: 4.142

3.  Oxysterols direct B-cell migration through EBI2.

Authors:  Changlu Liu; Xia V Yang; Jiejun Wu; Chester Kuei; Neelakandha S Mani; Li Zhang; Jingxue Yu; Steven W Sutton; Ning Qin; Homayon Banie; Lars Karlsson; Siquan Sun; Timothy W Lovenberg
Journal:  Nature       Date:  2011-07-27       Impact factor: 49.962

4.  Cholesterol-independent neuroprotective and neurotoxic activities of statins: perspectives for statin use in Alzheimer disease and other age-related neurodegenerative disorders.

Authors:  D Allan Butterfield; Eugenio Barone; Cesare Mancuso
Journal:  Pharmacol Res       Date:  2011-04-22       Impact factor: 7.658

Review 5.  Statins more than cholesterol lowering agents in Alzheimer disease: their pleiotropic functions as potential therapeutic targets.

Authors:  Eugenio Barone; Fabio Di Domenico; D Allan Butterfield
Journal:  Biochem Pharmacol       Date:  2013-11-11       Impact factor: 5.858

6.  Sex-related differences in urinary immune-related metabolic profiling of alopecia areata patients.

Authors:  Yu Ra Lee; Haksoon Kim; Bark Lynn Lew; Woo Young Sim; Jeongae Lee; Han Bin Oh; Jongki Hong; Bong Chul Chung
Journal:  Metabolomics       Date:  2020-01-16       Impact factor: 4.290

7.  Determination of Bile Acids in Piglet Bile by Solid Phase Extraction and Liquid Chromatography-Electrospray Tandem Mass Spectrometry.

Authors:  Si Mi; David W Lim; Justine M Turner; Paul W Wales; Jonathan M Curtis
Journal:  Lipids       Date:  2016-02-01       Impact factor: 1.880

8.  A validated LC-MS/MS assay for quantification of 24(S)-hydroxycholesterol in plasma and cerebrospinal fluid.

Authors:  Rohini Sidhu; Hui Jiang; Nicole Y Farhat; Nuria Carrillo-Carrasco; Myra Woolery; Elizabeth Ottinger; Forbes D Porter; Jean E Schaffer; Daniel S Ory; Xuntian Jiang
Journal:  J Lipid Res       Date:  2015-04-12       Impact factor: 5.922

Review 9.  Mass Spectrometry-based Lipidomics and Its Application to Biomedical Research.

Authors:  Zhexue Wu; Jong Cheol Shon; Kwang-Hyeon Liu
Journal:  J Lifestyle Med       Date:  2014-03-31

Review 10.  Detection technologies and metabolic profiling of bile acids: a comprehensive review.

Authors:  Yanan Liu; Zhihui Rong; Dong Xiang; Chengliang Zhang; Dong Liu
Journal:  Lipids Health Dis       Date:  2018-05-23       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.